Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission

NACompletedINTERVENTIONAL
Enrollment

1,393

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

February 15, 2020

Study Completion Date

February 15, 2020

Conditions
Patient Readmission
Interventions
OTHER

TARGET

The pre-discharge component includes mainly patient information, medication reconciliation, patient education, planning of a first post-discharge primary care physician visit with a timely discharge summary sent to the primary care physician. Two follow-up phone calls are made by a nurse, at D3 and D14, and include the assessment of the general health condition, the verification of the follow-up care plan, a reinforcement of the patient education, and review with the patient of the medication list with assessment of potential adverse drug events.

Trial Locations (4)

1005

Centre hospitalier universitaire vaudois (CHUV), Lausanne

1708

Hôpital cantonal Fribourg, Fribourg

2000

Hôpital neuchâtelois, Neuchâtel

2502

Centre hospitalier Bienne, Biel/Bienne

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

University of Bern

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03496896 - Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission | Biotech Hunter | Biotech Hunter